Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML

Xiao-Wei Zhang1, Xiao-Jing Yan, Zi-Ren Zhou

  • 1State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197 Rui Jin Road II, Shanghai 200025, China.

Science (New York, N.Y.)
|April 10, 2010
PubMed

Insights

Arsenic trioxide (As2O3) treats acute promyelocytic leukemia (APL) by targeting the PML-RARalpha oncogenic protein. This study reveals arsenic directly binds PML, enhancing its SUMOylation and degradation, offering new therapeutic insights.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Arsenic trioxide (As2O3) is a promising anticancer agent, particularly for acute promyelocytic leukemia (APL).
  • As2O3 promotes the degradation of the oncogenic PML-RARalpha fusion protein in APL cells.
  • The precise mechanism by which As2O3 induces PML-RARalpha degradation via SUMOylation remains unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism by which arsenic trioxide (As2O3) induces the degradation of PML and PML-RARalpha.
  • To identify the direct molecular target of As2O3 within the PML protein.

Main Methods:

  • Investigated the direct binding of arsenic to PML and PML-RARalpha proteins.
  • Utilized techniques to assess protein-protein interactions and posttranslational modifications, specifically SUMOylation.
  • Analyzed the effect of arsenic binding on PML oligomerization and its interaction with UBC9.

Main Results:

  • Demonstrated that arsenic directly binds to cysteine residues within the zinc fingers of the PML RBCC domain.
  • Showed that arsenic binding induces PML oligomerization.
  • Confirmed that arsenic-induced PML oligomerization enhances its interaction with UBC9, leading to increased SUMOylation and subsequent degradation.

Conclusions:

  • PML is a direct molecular target of arsenic trioxide (As2O3).
  • Arsenic binding to PML is the critical initiating event for enhanced SUMOylation and degradation of PML and PML-RARalpha.
  • This provides a mechanistic explanation for the specificity and efficacy of As2O3 in treating APL.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.